In this episode, Tom Caravela is joined by Jim Morgan to explore the unique landscape of working in small pharma companies. Jim shares insights from his extensive background in large pharma, highlighting the pros and challenges of transitioning to smaller firms. They discuss the critical role of field medical in companies lacking commercial teams and the recruitment challenges faced by small pharma. The conversation delves into strategic and tactical roles, team dynamics, and career progression within small biotech environments. Jim offers valuable advice for those considering a move to small pharma startups, emphasizing job stability and growth opportunities.
Jim Morgan, National Director, Oncology MSLs, discusses the KEY to success for working in small start ups vs. big pharma.
Jim shares…
👉 Pros and cons for Small vs. Large Pharma
👉 How to overcome lack of infrastructure and support
👉 What its like to navigate in an early stage, pre-commercial environment
👉 How to be both strategic and tactical at the same time
👉 What skills are mandatory for Small Pharma vs Large
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Karen Geary
J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret
Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys